Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$324M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$281M |
| 4 |
DuPont de Nemours
DD
|
+$278M |
| 5 |
HCC
HCC INSURANCES HOLDINGS INC
HCC
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$830M |
| 2 |
Johnson & Johnson
JNJ
|
+$281M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$205M |
| 4 |
Bausch Health
BHC
|
+$183M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.85% |
| 2 | Technology | 3.93% |
| 3 | Financials | 3.3% |
| 4 | Energy | 3.26% |
| 5 | Communication Services | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6401
IAMGOLD
IAG
$8.2B
| $1K | ﹤0.01% |
1,307
-23,182
| -95% | -$37.7K |
|
6402
Iovance Biotherapeutics
IOVA
$1.82B
| $1K | ﹤0.01% |
235
-626
| -73% | -$4.88K |
|
6403
Johnson Outdoors
JOUT
$491M
| $1K | ﹤0.01% |
26
-70
| -73% | -$1.61K |
|
6404
KRONOS Worldwide
KRO
$693M
| $1K | ﹤0.01% |
109
-315
| -74% | -$2.62K |
|
6405
KVH Industries
KVHI
$181M
| $1K | ﹤0.01% |
84
-222
| -73% | -$2.53K |
|
6406
Standard BioTools
LAB
$340M
| $1K | ﹤0.01% |
150
-402
| -73% | -$6.33K |
|
6407
Lifetime Brands
LCUT
$191M
| $1K | ﹤0.01% |
57
-148
| -72% | -$2.16K |
|
6408
CALL
L3Harris
LHX
$51.6B
| $1K | ﹤0.01% |
20
| – | – |
|
|
6409
PUT
L3Harris
LHX
$51.6B
| $1K | ﹤0.01% |
10
| – | – |
|
6410
LeMaitre Vascular
LMAT
$2.32B
| $1K | ﹤0.01% |
62
-165
| -73% | -$2.12K |
|
6411
CALL
LivePerson
LPSN
$21.8M
| $1K | ﹤0.01% |
7
| – | – |
|
|
6412
PUT
LivePerson
LPSN
$21.8M
| $1K | ﹤0.01% |
13
| – | – |
|
6413
PUT
Liquidity Services
LQDT
$1.22B
| $1K | ﹤0.01% |
200
-8,000
| -98% | -$66.4K |
|
6414
LSI Industries
LYTS
$859M
| $1K | ﹤0.01% |
113
-301
| -73% | -$2.82K |
|
6415
Marchex
MCHX
$76.2M
| $1K | ﹤0.01% |
220
-404
| -65% | -$1.72K |
|
6416
Mistras Group
MG
$484M
| $1K | ﹤0.01% |
88
-732
| -89% | -$11.7K |
|
6417
MGP Ingredients
MGPI
$379M
| $1K | ﹤0.01% |
56
-149
| -73% | -$2.33K |
|
6418
Miller Industries
MLR
$573M
| $1K | ﹤0.01% |
60
-158
| -72% | -$3.13K |
|
6419
Emerson Radio
MSN
$7.79M
| $1K | ﹤0.01% |
+900
| New | +$1.09K |
|
6420
BlackRock MuniYield Quality Fund III
MYI
$714M
| $1K | ﹤0.01% |
+96
| New | +$1.34K |
|
6421
Nature's Sunshine
NATR
$354M
| $1K | ﹤0.01% |
56
-145
| -72% | -$1.8K |
|
6422
NACCO Industries
NC
$357M
| $1K | ﹤0.01% |
92
-2,009
| -96% | -$24.7K |
|
6423
NeoGenomics
NEO
$1.96B
| $1K | ﹤0.01% |
280
-744
| -73% | -$4.61K |
|
6424
Vitamin Cottage Natural Grocers
NGVC
$739M
| $1K | ﹤0.01% |
46
-126
| -73% | -$3.03K |
|
6425
Natural Health Trends
NHTC
$14.7M
| $1K | ﹤0.01% |
41
-110
| -73% | -$3.33K |
|
Similar funds
Barclays's Q3 2015 Portfolio in Review
As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.
- Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
- Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
- Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
- Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
- Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
- Barclays opened 382 new positions and closed 515 in Q3 2015.
- Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.
Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.